Insmed Incorporated - stock earnings
INSM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -186.1 million USD | 83.7 million USD |
| 2023Q3 | -158.9 million USD | 79.1 million USD |
| 2023Q2 | -244.8 million USD | 77.2 million USD |
| 2023Q1 | -159.8 million USD | 65.2 million USD |
| 2022Q4 | -160.1 million USD | 59.3 million USD |
| 2022Q3 | -131.1 million USD | 67.7 million USD |
| 2022Q2 | -95.6 million USD | 65.2 million USD |
| 2022Q1 | -94.6 million USD | 53.1 million USD |
| 2021Q4 | -113.0 million USD | 56.1 million USD |
| 2021Q3 | -112.7 million USD | 46.8 million USD |
| 2021Q2 | -117.3 million USD | 45.4 million USD |
| 2021Q1 | -91.6 million USD | 40.2 million USD |
| 2020Q4 | -102.2 million USD | 41.4 million USD |
| 2020Q3 | -63.7 million USD | 43.6 million USD |
| 2020Q2 | -61.9 million USD | 42.5 million USD |
| 2020Q1 | -66.4 million USD | 36.9 million USD |
| 2019Q4 | -53.0 million USD | 45.7 million USD |
| 2019Q3 | -60.7 million USD | 38.9 million USD |
| 2019Q2 | -66.5 million USD | 30.0 million USD |
| 2019Q1 | -74.2 million USD | 21.9 million USD |
| 2018Q4 | -91.6 million USD | 9.8 million USD |
| 2018Q3 | -87.7 million USD | ? USD |
| 2018Q2 | -76.4 million USD | ? USD |
| 2018Q1 | -68.5 million USD | ? USD |
| 2017Q4 | -65.4 million USD | ? USD |
| 2017Q3 | -45.2 million USD | ? USD |
| 2017Q2 | -44.7 million USD | ? USD |
| 2017Q1 | -37.4 million USD | ? USD |
| 2016Q4 | -68.4 million USD | ? USD |
| 2016Q3 | -37.8 million USD | ? USD |
| 2016Q2 | -36.6 million USD | ? USD |
| 2016Q1 | -33.5 million USD | ? USD |
| 2015Q4 | -31.2 million USD | ? USD |
| 2015Q3 | -31.0 million USD | ? USD |
| 2015Q2 | -28.6 million USD | ? USD |
| 2015Q1 | -27.4 million USD | ? USD |
| 2014Q4 | -17.6 million USD | 11.5 million USD |
| 2014Q3 | -24.0 million USD | ? USD |
| 2014Q2 | -23.2 million USD | ? USD |
| 2014Q1 | -14.3 million USD | ? USD |
| 2013Q4 | -16.2 million USD | -11.5 million USD |
| 2013Q3 | -17.3 million USD | 11.5 million USD |
| 2013Q2 | -8.9 million USD | 11.5 million USD |
| 2013Q1 | -13.7 million USD | ? USD |
| 2012Q4 | -15.5 million USD | ? USD |
| 2012Q3 | -9.4 million USD | ? USD |
| 2012Q2 | -9.7 million USD | ? USD |
| 2012Q1 | -6.8 million USD | 1.4 million USD |
| 2011Q4 | -8.2 million USD | 1.4 million USD |
| 2011Q3 | -34.6 million USD | 435000 USD |
| 2011Q2 | -10.0 million USD | 978000 USD |
| 2011Q1 | -6.9 million USD | 1.6 million USD |
| 2010Q4 | -5.8 million USD | 1.3 million USD |
| 2010Q3 | -330000 USD | 1.8 million USD |
| 2010Q2 | -378000 USD | 1.9 million USD |
| 2010Q1 | 118000 USD | 1.9 million USD |
| 2009Q4 | 2.3 million USD | 2.5 million USD |
| 2009Q3 | -150000 USD | 2.5 million USD |
| 2009Q2 | -1.6 million USD | 3.0 million USD |
| 2009Q1 | 117.8 million USD | 2.4 million USD |
| 2008Q4 | -4.0 million USD | 2.9 million USD |
| 2008Q3 | -2.2 million USD | 4.1 million USD |
| 2008Q2 | -4.7 million USD | 2.6 million USD |
| 2008Q1 | -4.9 million USD | 2.3 million USD |
| 2007Q4 | -3.3 million USD | 2.1 million USD |
| 2007Q3 | -3.9 million USD | 1.5 million USD |
| 2007Q2 | -2.5 million USD | 2.3 million USD |
| 2007Q1 | -10.3 million USD | 1.7 million USD |
| 2006Q4 | -21.4 million USD | 502000 USD |
| 2006Q3 | -12.4 million USD | 226000 USD |
| 2006Q2 | -8.9 million USD | 210000 USD |
| 2006Q1 | -13.4 million USD | 54000 USD |
| 2005Q4 | -12.9 million USD | 24000 USD |
| 2005Q3 | -13.8 million USD | 22000 USD |
| 2005Q2 | -8.5 million USD | 28000 USD |
| 2005Q1 | -5.8 million USD | 57000 USD |
| 2004Q4 | -5.8 million USD | 23000 USD |
| 2004Q3 | -7.6 million USD | 24000 USD |
| 2004Q2 | -9.0 million USD | 29000 USD |
| 2004Q1 | -4.8 million USD | 61000 USD |
| 2003Q4 | -2.5 million USD | 27000 USD |
| 2003Q3 | -2.4 million USD | 27000 USD |
| 2003Q2 | -3.2 million USD | 34000 USD |
| 2003Q1 | -2.2 million USD | 62000 USD |
| 2002Q4 | -18.5 million USD | 26000 USD |
| 2002Q3 | -4.7 million USD | 1.8 million USD |
| 2002Q2 | -7.1 million USD | 70000 USD |
| 2002Q1 | -6.1 million USD | 102000 USD |
| 2001Q4 | -9.9 million USD | 61000 USD |
| 2001Q3 | -8.4 million USD | 66000 USD |
| 2001Q2 | -8.8 million USD | 69000 USD |
| 2001Q1 | -10.1 million USD | 100000 USD |
| 2000Q4 | -7.9 million USD | -83000 USD |
| 2000Q3 | -5.1 million USD | 53000 USD |
| 2000Q2 | -11.3 million USD | 90000 USD |
| 2000Q1 | -11.3 million USD | 90000 USD |
| 1999Q2 | -1.6 million USD | 236000 USD |
| 1999Q1 | -1.5 million USD | 168000 USD |
INSM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -749.6 million USD | 305.2 million USD |
| 2022 | -481.5 million USD | 245.4 million USD |
| 2021 | -434.7 million USD | 188.5 million USD |
| 2020 | -294.1 million USD | 164.4 million USD |
| 2019 | -254.3 million USD | 136.5 million USD |
| 2018 | -324.3 million USD | 9.8 million USD |
| 2017 | -192.6 million USD | ? USD |
| 2016 | -176.3 million USD | ? USD |
| 2015 | -118.2 million USD | ? USD |
| 2014 | -79.2 million USD | 11.5 million USD |
| 2013 | -56.1 million USD | 11.5 million USD |
| 2012 | -41.4 million USD | ? USD |
| 2011 | -59.7 million USD | 4.4 million USD |
| 2010 | -6.4 million USD | 6.9 million USD |
| 2009 | 118.4 million USD | 10.4 million USD |
| 2008 | -15.7 million USD | 11.7 million USD |
| 2007 | -20.0 million USD | 7.5 million USD |
| 2006 | -56.1 million USD | 991000 USD |
| 2005 | -40.9 million USD | 131000 USD |
| 2004 | -27.2 million USD | 137000 USD |
| 2003 | -10.3 million USD | 150000 USD |
| 2002 | -36.4 million USD | 2.0 million USD |
| 2001 | -37.2 million USD | 296000 USD |
| 2000 | -79.9 million USD | 60000 USD |
| 1999 | -7.8 million USD | 663162 USD |
INSM
Price: $25.55
52 week price:
Earnings Per Share: -5.34 USD
P/E Ratio: -5.48
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.3 million
Ebitda: -42.9 millionMarket Capitalization: 4.0 billion